Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Maternal vitamin D levels during pregnancy and offspring schizophrenia

Study design awaiting verification · Schizophrenia research · 2024

Original publication title

Maternal vitamin D levels during pregnancy and offspring schizophrenia

Andre Sourander; Subina Upadhyaya; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; Sanju Silwal; Ian W. McKeague; Alan S. Brown

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Maternal vitamin D levels in early pregnancy were not associated with offspring schizophrenia. Future studies measuring vitamin D during different stages of gestation are needed to draw firm conclusions.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Findings from previous studies on maternal 25(OH)D levels during pregnancy and offspring schizophrenia are limited and inconsistent.

Source: Background:

Abstract: What methods does the paper describe?

We used nationwide population-based register data with a nested case-control design to examine the association between maternal 25(OH)D levels during pregnancy and offspring schizophrenia. The cases of schizophrenia (n = 1145) were born from 1987 to 1997, and received a diagnosis of schizophrenia by 2017, and were matched with equal number of controls. A quantitative immunoassay was used to measure maternal 25 (OH)D in archived maternal serum in the national biobank of the Finnish Maternity Cohort, collected during the first and early second trimesters.

Conditional logistic regression models examined the association between maternal 25(OH)D levels and offspring schizophrenia.

Source: Methods:

Abstract: Results

No significant association was found between log-transformed maternal 25(OH)D levels and schizophrenia in unadjusted (OR 0.96, 95 % CI 0.78 to 1.17, p = 0.69) or adjusted analyses (aOR 0.98, 95 % CI 0.79 to 1.22, p = 0.89). Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71). Maternal 25(OH)D levels, measured in categories, either in deficient category (OR 1.07 (0.85 to 1.35), p = 0.52; aOR 1.05 (0.81 to 1.34), p = 0.88) or insufficient category (OR 1.13, 95 % CI 0.92 to 1.40, p = 0.23; aOR 1.13, 95 % CI 0.90 to 1.41, p = 0.27) were also not associated with offspring schizophrenia.

Source: Results:

Abstract: Conclusions

Maternal vitamin D levels in early pregnancy were not associated with offspring schizophrenia. Future studies measuring vitamin D during different stages of gestation are needed to draw firm conclusions.

Source: Conclusions:
Authors’ abstract

Background:

Findings from previous studies on maternal 25(OH)D levels during pregnancy and offspring schizophrenia are limited and inconsistent.

Methods:

We used nationwide population-based register data with a nested case-control design to examine the association between maternal 25(OH)D levels during pregnancy and offspring schizophrenia. The cases of schizophrenia (n = 1145) were born from 1987 to 1997, and received a diagnosis of schizophrenia by 2017, and were matched with equal number of controls. A quantitative immunoassay was used to measure maternal 25 (OH)D in archived maternal serum in the national biobank of the Finnish Maternity Cohort, collected during the first and early second trimesters.

Conditional logistic regression models examined the association between maternal 25(OH)D levels and offspring schizophrenia.

Results:

No significant association was found between log-transformed maternal 25(OH)D levels and schizophrenia in unadjusted (OR 0.96, 95 % CI 0.78 to 1.17, p = 0.69) or adjusted analyses (aOR 0.98, 95 % CI 0.79 to 1.22, p = 0.89). Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71). Maternal 25(OH)D levels, measured in categories, either in deficient category (OR 1.07 (0.85 to 1.35), p = 0.52; aOR 1.05 (0.81 to 1.34), p = 0.88) or insufficient category (OR 1.13, 95 % CI 0.92 to 1.40, p = 0.23; aOR 1.13, 95 % CI 0.90 to 1.41, p = 0.27) were also not associated with offspring schizophrenia.

Conclusions:

Maternal vitamin D levels in early pregnancy were not associated with offspring schizophrenia. Future studies measuring vitamin D during different stages of gestation are needed to draw firm conclusions.

Publication and source details

Original title: Maternal vitamin D levels during pregnancy and offspring schizophrenia

Andre Sourander; Subina Upadhyaya; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; Sanju Silwal; Ian W. McKeague; Alan S. Brown

Schizophrenia research · 2024

1

Shared authorship.

* Corresponding author at: Research Centre for Child Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Turku, Lemminkäisenkatu 3/Teutori (3rd floor), 20014 Turku, Finland. andsou@utu.fi (A. Sourander).
https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:09:10.712550+00:00

DOI: 10.1016/j.schres.2024.06.039 · PMC11412259